220 related articles for article (PubMed ID: 29050469)
1. In Vivo [
Schoenberger M; Schroeder FA; Placzek MS; Carter RL; Rosen BR; Hooker JM; Sander CY
ACS Chem Neurosci; 2018 Feb; 9(2):298-305. PubMed ID: 29050469
[TBL] [Abstract][Full Text] [Related]
2. [
Zhou W; Bao W; Jiang D; Kong Y; Hua F; Lu X; Guan Y
Nucl Med Biol; 2018 Jun; 61():45-55. PubMed ID: 29747036
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex.
Samnick S; Ametamey S; Leenders KL; Vontobel P; Quack G; Parsons CG; Neu H; Schubiger PA
Nucl Med Biol; 1998 May; 25(4):323-30. PubMed ID: 9639292
[TBL] [Abstract][Full Text] [Related]
4. Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.
Murray F; Kennedy J; Hutson PH; Elliot J; Huscroft I; Mohnen K; Russell MG; Grimwood S
Eur J Pharmacol; 2000 Jun; 397(2-3):263-70. PubMed ID: 10844123
[TBL] [Abstract][Full Text] [Related]
5. Activation of NMDA receptor ion channels by deep brain stimulation in the pig visualised with [
Vibholm AK; Landau AM; Alstrup AKO; Jacobsen J; Vang K; Munk OL; Dietz MJ; Orlowski D; Sørensen JCH; Brooks DJ
Brain Stimul; 2020; 13(4):1071-1078. PubMed ID: 32388196
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptor ion channel activation detected in vivo with [
Vibholm AK; Landau AM; Møller A; Jacobsen J; Vang K; Munk OL; Orlowski D; Sørensen JC; Brooks DJ
J Cereb Blood Flow Metab; 2021 Jun; 41(6):1301-1312. PubMed ID: 32960687
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors.
Salabert AS; Fonta C; Fontan C; Adel D; Alonso M; Pestourie C; Belhadj-Tahar H; Tafani M; Payoux P
Nucl Med Biol; 2015 Aug; 42(8):643-53. PubMed ID: 25963911
[TBL] [Abstract][Full Text] [Related]
8. Comment on " In Vivo [
McGinnity CJ; Årstad E; Beck K; Brooks DJ; Coles JP; Duncan JS; Galovic M; Hinz R; Hirani E; Howes OD; Jones PA; Koepp MJ; Luo F; Riaño Barros DA; Singh N; Trigg W; Hammers A
ACS Chem Neurosci; 2019 Jan; 10(1):768-772. PubMed ID: 30346706
[TBL] [Abstract][Full Text] [Related]
9. Brain kinetics of (R)- and (S)-[N-methyl-11C]ketamine in the rhesus monkey studied by positron emission tomography (PET).
Hartvig P; Valtysson J; Antoni G; Westerberg G; Långström B; Ratti Moberg E; Oye I
Nucl Med Biol; 1994 Oct; 21(7):927-34. PubMed ID: 9234346
[TBL] [Abstract][Full Text] [Related]
10. Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using 18F-GE-179 and 18F-GE-194 Autoradiography.
López-Picón F; Snellman A; Shatillo O; Lehtiniemi P; Grönroos TJ; Marjamäki P; Trigg W; Jones PA; Solin O; Pitkänen A; Haaparanta-Solin M
J Nucl Med; 2016 Sep; 57(9):1442-7. PubMed ID: 27199360
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms.
Hiyoshi T; Kambe D; Karasawa J; Chaki S
Neuropharmacology; 2014 Oct; 85():384-96. PubMed ID: 24907590
[TBL] [Abstract][Full Text] [Related]
13. Brain NMDA Receptors in Schizophrenia and Depression.
Adell A
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585886
[TBL] [Abstract][Full Text] [Related]
14. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
Newell KA; Zavitsanou K; Huang XF
J Neural Transm (Vienna); 2007; 114(8):995-1001. PubMed ID: 17401537
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of (
Ahmed H; Zheng MQ; Smart K; Fang H; Zhang L; Emery PR; Gao H; Ropchan J; Haider A; Tamagnan G; Carson RE; Ametamey SM; Huang Y
J Nucl Med; 2022 Dec; 63(12):1912-1918. PubMed ID: 35710735
[TBL] [Abstract][Full Text] [Related]
16. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
Adams BW; Bradberry CW; Moghaddam B
Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
[TBL] [Abstract][Full Text] [Related]
17. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
Witkin JM; Steele TD; Sharpe LG
J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
[TBL] [Abstract][Full Text] [Related]
18. Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine.
De Vry J; Jentzsch KR
Behav Pharmacol; 2003 May; 14(3):229-35. PubMed ID: 12799525
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor.
Waterhouse RN; Slifstein M; Dumont F; Zhao J; Chang RC; Sudo Y; Sultana A; Balter A; Laruelle M
Nucl Med Biol; 2004 Oct; 31(7):939-48. PubMed ID: 15464396
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo characterization of [3H]CNS-5161--a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain.
Biegon A; Gibbs A; Alvarado M; Ono M; Taylor S
Synapse; 2007 Aug; 61(8):577-86. PubMed ID: 17455246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
